Seystahl K, Gramatzki D, Wanner M, Weber SJ, Hug A, Luft AR, Rohrmann S, Wegener S, Weller M. A risk model for prediction of diagnosis of cancer after ischemic stroke. Sci Rep. 2023;13(1):111. doi: 10.1038/s41598-022-26790-y. PMID: 36596831 https://pubmed.ncbi.nlm.nih.gov/36596831/
Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O’Brian DK, Saint-Jacques N, Coleman MP, Allemani C; CONCORD Working Group. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3). Neuro Oncol. 2022 Nov 10:noac217. doi: 10.1093/neuonc/noac217. https://pubmed.ncbi.nlm.nih.gov/36355361/
Seystahl K, Schweizer J, Katan M, Weber SJ, Hug A, Wanner M, Luft AR, Rohrmann S, Wegener S, Weller M. Stroke-associated infections in patients with and without cancer. Neurooncol Pract. 2022;10(2):176-185. doi: 10.1093/nop/npac075. PMID: 36970172 https://pubmed.ncbi.nlm.nih.gov/36970172/
Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, Saint-Jacques N, Minicozzi P, De P, Rodríguez-Barranco M, Larønningen S, Di Carlo V, Mägi M, Valkov M, Seppä K, Wyn Huws D, Coleman MP, Allemani C; CONCORD Working Group. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. 2022;6(6):409-431. PMID: 35468327 https://pubmed.ncbi.nlm.nih.gov/35468327/
Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland.
Montagna G, Schaffar R, Bordoni A, Spitale A, Terribile DA, Rossi L, Bergeron Y, van der Linden BWA, Konzelmann I, Rohrmann S, Staehelin K, Maspoli-Conconi M, Bulliard JL, Meani F, Pagani O, Rapiti E. Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland. Cancers (Basel). 2022 4;14(5):1328. PMID: 35267635 https://pubmed.ncbi.nlm.nih.gov/35267635/
Incidence and mortality trends of thyroid cancer from 1980 to 2016.
Wirth S, Syleouni ME, Karavasiloglou N, Rinaldi S, Korol D, Wanner M, Rohrmann S. Swiss Med Wkly. 2021 Nov 5;151:w30029. doi: 10.4414/smw.2021.w30029. eCollection 2021 Oct 25.PMID: 34751539
Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study.
Michalopoulou E, Matthes KL, Karavasiloglou N, Wanner M, Limam M, Korol D, Held L, Rohrmann S. Cancer Epidemiol. 2021 Aug;73:101962. doi: 10.1016/j.canep.2021.101962. Epub 2021 May 26.PMID: 34051687
Cancer is associated with inferior outcome in patients with ischemic stroke.
Seystahl K, Hug A, Weber SJ, Kapitza S, Gramatzki D, Wanner M, Katan M, Luft AR, Rohrmann S, Wegener S, Weller M. J Neurol. 2021 Nov;268(11):4190-4202. doi: 10.1007/s00415-021-10528-3. Epub 2021 May 4.PMID: 33945004
Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS).
Adam S, Thong MSY, Martin-Diener E, Camey B, Egger Hayoz C, Konzelmann I, Mousavi SM, Herrmann C, Rohrmann S, Wanner M, Staehelin K, Strebel RT, Randazzo M, John H, Schmid HP, Feller A, Arndt V. Support Care Cancer. 2021 Nov;29(11):6259-6269. doi: 10.1007/s00520-021-06132-w. Epub 2021 Apr 13.PMID: 33847829
Risk for Invasive Cancers in Women With Breast Cancer In Situ: Results From a Population Not Covered by Organized Mammographic Screening.
Karavasiloglou N, Matthes KL, Pestoni G, Limam M, Korol D, Wanner M, Rohrmann S. Front Oncol. 2021 Mar 18;11:606747. doi: 10.3389/fonc.2021.606747. eCollection 2021.PMID: 33816240
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).
Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, Rodrigues JR, Herrmann C, Marcos-Gragera R, Peris-Bonet R, Valkov M, Weir HK, Woods RR, You H, Cueva PA, De P, Di Carlo V, Johannesen TB, Lima CA, Lynch CF, Coleman MP, Allemani C; CONCORD Working Group.Neuro Oncol. 2021 Oct 1;23(10):1765-1776. doi: 10.1093/neuonc/noab067.PMID: 33738488
Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, Rodrigues JR, Herrmann C, Marcos-Gragera R, Peris-Bonet R, Valkov M, Weir HK, Woods RR, You H, Cueva PA, De P, Di Carlo V, Johannesen TB, Lima CA, Lynch CF, Coleman MP, Allemani C; CONCORD Working Group. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro Oncol. 2021 1;23(10):1765-1776. PMID: 33738488 (fehlt noch in 2021)
Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.
Limam M, Matthes KL, Pestoni G, Michalopoulou E, Held L, Dehler S, Korol D, Rohrmann S.J Cancer Res Clin Oncol. 2021 May;147(5):1407-1419. doi: 10.1007/s00432-021-03557-y. Epub 2021 Mar 4.PMID: 33661394
37-year incidence and mortality time trends of common cancer types by sex, age, and stage in the canton of Zurich.
Wanner M, Matthes KL, Karavasiloglou N, Limam M, Korol D, Rohrmann S. Swiss Med Wkly. 2020 Dec 14;150:w20388. doi: 10.4414/smw.2020.20388. eCollection 2020 Dec 14. PMID: 33378540
Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country.
Wanner M, Rohrmann S, Korol D, Shenglia N, Gigineishvili T, Gigineishvili D. J Neurooncol. 2020 Sep;149(2):273-282. doi: 10.1007/s11060-020-03595-5. Epub 2020 Aug 19. PMID: 32813185
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug.
Stahel RA, Curioni-Fontecedro A, Rohrmann S, Dafni U, Sandner U, Opitz I, Andratschke N, Franzen D, Dimopoulou G, Matthes KL, Kohler M, Guckenberger M, Weder W.Lung Cancer. 2020 Aug;146:217-223. doi: 10.1016/j.lungcan.2020.05.037. PMID: 32569900
Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.
Adam S, Martin-Diener E, Camey B, Egger Hayoz C, Konzelmann I, Mohsen Mousavi S, Herrmann C, Rohrmann S, Wanner M, Staehelin K, Strebel RT, Randazzo M, John H, Schmid HP, Arndt V. Cancer Med. 2020 Aug;9(15):5416-5424. doi: 10.1002/cam4.3197. PMID: 32524704
Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.
Feller A, Bopp M, Lorez M, Zellweger U, Adam M, Curjuric I, Staehelin K, Perren A, Bergeron Y, Rapiti E, Mousavi M, Diebold J, Dyntar D, Bulliard JL, Maspoli Conconi M, Bordoni A, Konzelmann I, Wagner U, Rohrmann S. Swiss Med Wkly. 2020 Feb 7;150:w20179. doi: 10.4414/smw.2020.20179. PMID: 32031233
Progressive Disease in Sentinel-negative Melanoma Patients: Biological Differences and Importance of Sentinel Lymph Node Biopsy.
Conrad A, Reinehr M, Holzmann D, Mangana J, Wanner M, Huellner M, Barnhill RL, Lugassy C, Lindenblatt N, Mihic-Probst D.Anticancer Res. 2020 Feb;40(2):891-899. doi: 10.21873/anticanres.14022.PMID: 32014933
The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
Feller A, Matthes KL, Bordoni A, Bouchardy C, Bulliard JL, Herrmann C, Konzelmann I, Maspoli M, Mousavi M, Rohrmann S, Staehelin K, Arndt V; NICER Working Group. BMC Cancer. 2020 Jan 21;20(1):51. doi: 10.1186/s12885-019-6452-0. PMID: 31964352
Underweight and weight loss are predictors of poor outcome in patients with brain metastasis.
Lareida A, Terziev R, Grossenbacher B, Andratschke N, Roth P, Rohrmann S, Stahel R, Guckenberger M, Le Rhun E, Weller M, Wolpert F. J Neurooncol. 2019 Nov;145(2):339-347. doi: 10.1007/s11060-019-03300-1. PMID: 31571112
Ruffieux Y, Chammartin F, Feller A, Schmidlin K, Rohrmann S, Staehelin K, Bouchardy C, Bucher HC, Hasse B, Cavassini M, Calmy A, Wandeler G, Scherrer A, Bohlius J, Egger M. Non-AIDS defining malignancies in the combination ART era: immunological and socio-behavioral risk factors [version 1; peer review: 2 approved with reservations]. F1000Research 2019, 8:1400 (https://doi.org/10.12688/f1000research.19585.1)
Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003-2014. Karavasiloglou N, Matthes KL, Berlin C, Limam M, Wanner M, Korol D, Rohrmann S. J Cancer Res Clin Oncol. 2019 Mar;145(3):653-660. doi: 10.1007/s00432-018-2822-2. PMID: 30547321
Ess SM, Herrmann C, Bouchardy C, Neyroud I, Rapiti E, Konzelmann I, Bordoni A, Ortelli L, Rohrmann S, Frick H, Mousavi M, Thürlimann B.
Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies.
Breast. 2018 Oct;41:151-158. doi: 10.1016/j.breast.2018.07.011.
Binder C, Matthes KL, Korol D, Rohrmann S, Moch H.
Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.
Cancer Med. 2018 Sep;7(9):4814-4824.
Adam S, Feller A, Rohrmann S, Arndt V.
Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Health Qual Life Outcomes. 2018 Jan 23;16(1):22. doi: 10.1186/s12955-017-0836-0. Review. Erratum in: Health Qual Life Outcomes. 2018 Aug 7;16(1):162.
Wanner M, Matthes KL, Korol D, Dehler S, Rohrmann S.
Indicators of Data Quality at the Cancer Registry Zurich and Zug in Switzerland.
Biomed Res Int. 2018 Jun 13;2018:7656197.
Matthes KL, Pestoni G, Korol D, Van Hemelrijck M, Rohrmann S.
The risk of prostate cancer mortality and cardiovascular mortality of nonmetastatic prostate cancer patients: A population-based retrospective cohort study.
Urol Oncol. 2018 Jun;36(6):309.e15-309.e23.
Gramatzki D, Roth P, Rushing EJ, Weller J, Andratschke N, Hofer S, Korol D, Regli L, Pangalu A, Pless M, Oberle J, Bernays R, Moch H, Rohrmann S, Weller M.
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study.
Ann Oncol. 2018 Jun 1;29(6):1431-1436.
Matthes KL, Limam M, Pestoni G, Held L, Korol D, Rohrmann S.
Impact of comorbidities at diagnosis on prostate cancer treatment and survival.
J Cancer Res Clin Oncol. 2018 Apr;144(4):707-715.
Wanner M, Richard A, Matthes K, Ortelli L, Lorez M, Korol D, Bordoni A, Rohrmann S.
Trends in prostate cancer incidence between 1996 and 2013 in two Swiss regions by age, grade, and T-stage.
Cancer Causes Control. 2018 Feb;29(2):269-277.
Steliarova-Foucher E, Fidler MM, Colombet M, Lacour B, Kaatsch P, Piñeros M, Soerjomataram I, Bray F, Coebergh JW, Peris-Bonet R, Stiller CA; ACCIS contributors.
Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study.
Lancet Oncol. 2018 Sep;19(9):1159-1169.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group.
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
Lancet. 2018 Mar 17;391(10125):1023-1075.
Matthes KL, Limam M, Pestoni G, Held L, Korol D, Rohrmann S.
Impact of comorbidities at diagnosis on prostate cancer treatment and survival.
J Cancer Res Clin Oncol. 2018 Feb 7. doi: 10.1007/s00432-018-2596-6 [Epub ahead of print].
Adam S, Feller A, Rohrmann S, Arndt V.
Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Health Qual Life Outcomes. 2018 Jan 23;16(1):22. doi: 10.1186/s12955-017-0836-0.
Matthes KL, Limam M, Dehler S, Korol D, Rohrmann S.
Primary Treatment Choice Over Time and Relative Survival of Prostate Cancer Patients: Influence of Age, Grade, and Stage.
Oncol Res Treat. 2017;40(9):484-489
Richard A, Faeh D, Bopp M, Rohrmann S.
Diet and Other Lifestyle Factors Associated with Prostate Cancer Differ Between the German and Italian Region of Switzerland.
Int J Vitam Nutr Res. 2017 Dec 8:1-8. doi: 10.1024/0300-9831/a000433. [Epub ahead of print].
Wanner M, Richard A, Matthes K, Ortelli L, Lorez M, Korol D, Bordoni A, Rohrmann S.
Trends in prostate cancer incidence between 1996 and 2013 in two Swiss regions by age, grade, and T-stage.
Cancer Causes & Control. 2017 Dec 4. doi: 10.1007/s10552-017-0993-9.
Van Hemelrijck M, Karagiannis SN, Rohrmann S.
Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?
Eur Heart J Acute Cardiovasc Care. 2017 Sep 1:2048872617729636. doi: 10.1177/2048872617729636 [Epub ahead of print].
Rohrmann S, Witassek F, Erne P, Rickli H, Radovanovic D.
Treatment of patients with myocardial infarction depends on history of cancer.
Eur Heart J Acute Cardiovasc Care. 2017 Sep 1:2048872617729636. doi: 10.1177/2048872617729636 [Epub ahead of print].
Lorez M, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Dehler S, Frick H, Konzelmann I, Maspoli M, Mousavi SM, Rohrmann S, Arndt V.
Evaluation of completeness of case ascertainment in Swiss cancer registration.
Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S139-S146. doi: 10.1097/CEJ.0000000000000380.
Rohrmann S, Cabaset S, Linseisen J.
Fleischkonsum und Krebsrisiko – darf man noch Fleisch essen?
Praxis (Bern 1994). 2017 Aug;106(16):871-876. doi: 10.1024/1661-8157/a002747.
El Saadany T, Richard A, Wanner M, Rohrmann S.
Sex-specific effects of leisure-time physical activity on cause-specific mortality in NHANES III.
Prev Med. 2017 Aug;101:53-59. doi: 10.1016/j.ypmed.2017.05.029. Epub 2017 Jun 1.
Smith K, Byrne1, Castaño JM, Chirlaque MD, Lilja H, Agudo A, Ardanaz E, Rodríguez-Barranco M, Boeing H, Kaaks R, Khaw KT, Larrañaga N, Navarro C, Olsen A, Overvad K, Perez-Cornago A, Rohrmann S, Sánchez MJ, Tjønneland A, Tsilidis KK, Johansson M, Riboli E, Key TJ, Travis RC.
Vasectomy and Prostate Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC).
J Clin Oncol. 2017 Apr 20;35(12):1297-1303. doi: 10.1200/JCO.2016.70.0062. Epub 2017 Mar 6.
Matthes KL, Limam M, Dehler S, Korol D, Rohrmann S.
Primary Treatment Choice Over Time and Relative Survival of Prostate Cancer Patients: Influence of Age, Grade, and Stage.
Oncol Res Treat. 2017;40(9):484-489. doi: 10.1159/000477096. Epub 2017 Aug 17.
Wanner M, Richard A, Martin B, Faeh D, Rohrmann S.
Associations between self-reported and objectively measured physical activity, sedentary behavior and overweight/obesity in NHANES 2003-2006.
Int J Obes (Lond). 2017 Jan;41(1):186-193. doi: 10.1038/ijo.2016.168. Epub 2016 Sep 28.
Minini R, Rohrmann S, Braun R, Korol D, Dehler S.
Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the canton of Zurich, Switzerland.
Melanoma Res. 2016 Dec 6. [Epub ahead of print]
Beleut M, Soeldner R, Egorov M, Guenther R, Dehler S, Morys-Wortmann C, Moch H, Henco K, Schraml P.
Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types.
PLoS One. 2016 Aug 18;11(8):e0161514. doi: 10.1371/journal.pone.0161514.
Oberli LS, Valeri F, Korol D, Rohrmann S, Dehler S.
31 years of lung cancer in the canton of Zurich, Switzerland: incidence trends by sex, histology and laterality.
Swiss Med Wkly. 2016 Jul 11;146:w14327. doi: 10.4414/smw.2016.14327.
Ernst J, Ikenberg K, Apel B, Schumann DM, Huber G, Studer G, Rordorf T, Riesterer O, Rössle M, Korol D, Bredell MG.
Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
Oncotarget. 2016 Nov 15;7(46):76151-76158. doi: 10.18632/oncotarget.12691.
Rössle M, Cathomas G, Bonapace L, Sachs M, Dehler S, Storz M, Huber G, Moch H, Junt T, Mertz KD.
Interleukin-33 Expression Indicates a Favorable Prognosis in Malignant Salivary Gland Tumors.
Int J Surg Pathol. 2016 Aug ;24(5):394-400. ; doi: 10.1177/1066896916633856.
Gramatzki D, Dehler S, Rushing EJ, Zaugg K, Hofer S, Yonekawa Y, Bertalanffy H, Valavanis A, Korol D, Rohrmann S, Pless M, Oberle J, Roth P, Ohgaki H, Weller M.
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
Cancer. 2016 Jul 15;122(14):2206-15. doi: 10.1002/cncr.30023. Epub 2016 Apr 18.
Gugger A, Barnhill RL, Seifert B, Dehler S, Moch H, Lugassy C, Marques-Maggio E, Rushing EJ, Mihic-Probst D.
Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.
PLoS One. 2016 May 23;11(5):e0156115. doi: 10.1371/journal.pone.0156115.
Clifford GM, Franceschi S, Keiser O, Schöni-Affolter F, Lise M, Dehler S, Levi F, Mousavi M, Bouchardy C, Wolfensberger A, Darling KE, Staehelin C, Bertisch B, Kuenzli E, Bernasconi E, Pawlita M, Egger M.
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.
Int J Cancer. 2016 Apr 1; 138(7):1732-40. doi: 10.1002/ijc.29913 .
Christen S, Vetsch J, Mader L, Dehler S, Korol D, Kuehni C, Rueegg CS, Michel G.
Preferences for the organization of long-term follow-up in adolescent and young adult cancer survivors.
Supportive Care in Cancer J. 2016 Mar 18.
Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Konzelmann I, Mousavi M, Clough-Gorr KM, Szucs T, Schwenkglenks M, Pestalozzi BC.
Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09).
Eur J Cancer Care (Engl). 2016 Feb 9. doi: 10.1111/ecc.12453.
Feller A, Fehr M, Bordoni A, Bouchardy C, Frick H, Mousavi M, Steiner A, Arndt V, Clough-Gorr KM; Nicer Working Group.
Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.
Swiss Med Wkly. November 2015, Dec 10, doi: 10.4414/smw.2015.14245.
Pomp V, Leo C, Mauracher A, Korol D, Guo W, Varga Z.
Differential expression of epithelial-mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Breast Cancer Research and Treatment. November 2015, Volume 154, Issue 1, pp 45-55
Epub 2015 Oct 14.
Thies S, Friess M, Frischknecht L, Korol D, Felley-Bosco E, Stahel R, Vrugt B, Weder W, Opitz I, Soltermann A.
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.
PLoS One. 2015 Sep 30;10(9):e0139312. doi: 10.1371/journal.pone.0139312. eCollection 2015.
Prater J, Valeri F, Korol D, Rohrmann S, Dehler S.
Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
J Cancer Res Clin Oncol. 2015 Aug 23.
Steliarova-Foucher E, Stiller C, Colombet M, Kaatsch P, Zanetti R, Peris-Bonet R.
Registration of childhood cancer: Moving towards pan-European coverage?
Eur J Cancer. 2015 Apr 17. pii: S0959-8049(15)00225-7. doi: 10.1016/j.ejca.2015.03.009.
Pflueger D, Mittmann C, Dehler S, Rubin M, Moch H, Schraml P.
Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer.
BMC Genomics 2015 Mar 27, 16:247 doi:10.1186/s12864-015-1446-z
Bieri U, Moch H, Dehler S, Korol D, Rohrmann S.
Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich.
Virchows Arch. 2015 Mar 7, doi:10.1007/s00428-015-1734-7
Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Jundt G, Konzelmann I, Clough-Gorr K, Szucs T, Pestalozzi BC, Schwenkglenks M.
Cancer-Related Therapies at the End of Life in Hospitalized Cancer Patients from Four Swiss Cantons: SAKK 89/09.
Oncology.2015;88(1):18-27. doi: 10.1159/000367629. Epub 2014 Sep 26.
Hitz F, Arndt V, Lorez M, and the NICER Working Group.
Survival Trends for non-Hodgkin lymphoma patients in Switzerland.
Schweizer Krebsbulletin 1/2015, 61-66.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo E Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; the CONCORD Working Group.
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Lancet, 2014 Nov 26. pii: S0140-6736(14)62038-9. doi: 10.1016/S0140-6736(14)62038-9.
Alexandre Bodmer, Anita Feller, Andrea Bordoni, Christine Bouchardy, Silvia Dehler, Silvia Ess, Fabio Levi, Isabelle Konzelmann, Elisabetta Rapiti, Annik Steiner, Kerri M. Clough-Gorr, the NICER Working Group
Breast cancer in younger women in Switzerland 1996–2009: A longitudinal population-based study.
The Breast, 2014.
Dehler S, Tonev S, Korol D, Rohrmann S, Dimitrova N.
Recent trends in cancer incidence: impact of risk factors, diagnostic activities and data quality of registration.
Tumori. 2014 Jul-Aug;100(4):399-405. doi: 10.1700/1636.17894.
Van Hemelrijck M, Feller A, Garmo H, Valeri F, Korol D, Dehler S, Rohrmann S.
Incidence of second malignancies for prostate cancer.
PLoS One. 2014 Jul 21;9(7):e102596. doi: 10.1371/journal.pone.0102596. eCollection 2014.
Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Jundt G, Konzelmann I, Clough-Gorr KM, Szucs TD, Schwenkglenks M, Pestalozzi BC.
Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09).
BMC Cancer. 2014 May 1;14:306. doi: 10.1186/1471-2407-14-306.
Thomas Ruhstaller, Volker Arndt, Matthias Lorez and the NICER Working Group
Trends in survival from oesophageal cancer in Switzerland.
Schweizer Krebs Bulletin 3-2014
Viola Heinzelmann-Schwarz, Matthias Lorez and the NICER Working Group
Trends in Survival from Cancer of the Corpus uteri in Switzerland.
Schweizer Krebs Bulletin 2-2014
Jean-Francois Dufour, Andrea Bordoni, Matthias Lorez and the NICER Working Group
Trends in Hepatic Cancer Survival in Switzerland.
Schweizer Krebs Bulletin 1-2014
Bertisch B, Franceschi S, Lise M, Vernazza P, Keiser O, Schöni-Affolter F, Bouchardy C, Dehler S, Levi F, Jundt G, Ess S, Pawlita M, Kovari H, Wandeler G, Calmy A, Cavassini M, Stöckle M, Clifford G; Swiss HIV Cohort Study Investigators.
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
Am J Epidemiol. 2013 Sep 15;178(6):877-84. doi: 10.1093/aje/kwt153. Epub 2013 Jul 30.
Tinguely M, Thies S, Frigerio S, Reineke T, Korol D, Zimmermann DR.
IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1).
Leuk Lymphoma. 2013 Jun 12. [Epub ahead of print]
Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R; the EUROCARE Working Group.
Cancer prevalence estimates in Europe at the beginning of 2000.
Ann Oncol. 2013 Apr 3. [Epub ahead of print]
Zimmermann AK, Imig J, Klar A, Renner C, Korol D, Fink D, Stadlmann S, Singer G, Knuth A, Moch H, Caduff R.
Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.
Virchows Arch. 2013 May;462(5):565-74. doi: 10.1007/s00428-013-1395-3. Epub 2013 Mar 26.
Montemurro M, Lorez M, NICER Working Group.
Trends in pancreatic cancer survival in Switzerland.
Schweizer Krebsbulletin 2013(4).
Spitale A, Feller A, Lorez M, NICER Working Group.
Trends in stomach cancer survival in Switzerland.
Schweizer Krebsbulletin 2013(3).
C. Bouchardy, M. Lorez, K. Clough-Gorr, NICER Working Group.
Trends in Bladder Cancer survival in Switzerland.
Schweizer Krebsbulletin 2013(2).
Dehler S, Rohrmann S, Lorez M, Clough-Gorr K, NICER Working Group.
Trends in prostate cancer survival in Switzerland.
Schweizer Krebsbulletin 2013(1).
Soldini D, Montagna C, Schüffler P, Martin V, Georgis A, Thiesler T, Curioni-Fontecedro A, Went P, Bosshard G, Dehler S, Mazzuchelli L, Tinguely M.
A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.
Ann Oncol. 2013 Jan;24(1):193-201. doi: 10.1093/annonc/mds209. Epub 2012 Sep 11.
Bordoni A, Lorez M, Bouchardy C, Camey B, Betticher D, Dehler S, Gautschi O, Konzelmann I, Clough-Gorr K, NICER Working Group.
Trends in Lung Cancer Survival in Switzerland.
Schweizer Krebsbulletin 2012(3):240-244.
M. Joerger, B. Thürlimann, A. Savidan, H. Frick, C. Rageth, U. Lütolf, G. Vlastos, C. Bouchardy, I. Konzelmann, A. Bordoni, N. Probst-Hensch, G. Jundt, S. Ess.
Treatment of breast cancer in the elderly: A prospective, population-based Swiss study
J Geriatr Oncol (2012)
Elodie Roy, Natascha Wyss.
Hautmelanom: Bestandesaufnahme und Prävention
Bundesamt für Statistik BFS, BFS Aktuell, 14 Gesundheit, Neuchâtel, 16.04.2012.
Joerger M, Thürlimann B, Savidan A, Frick H, Bouchardy C, Konzelmann I, Probst-Hensch N, Ess S.
A population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer.
Clin Breast Cancer. 2012 Apr;12(2):102-9. Epub 2011 Dec 3.
Joerger M, Ess S, Dehler S, Savidan A, Bouchardy C, Frick H, Konzelmann I, Thürlimann B.
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.
Swiss Med Wkly. 2012 Apr 11;142:0. doi: 10.4414/smw.2012.13571.
Aigner F, Korol D, Schmitt AM, Kurrer MO.
Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
Histopathology. 2012 Apr;60(5):774-84. doi: 10.1111/j.1365-2559.2011.04122.x. Epub 2012 Feb 3.
Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, Levi F, Ess S, Jundt G, Wandeler G, Fehr J, Schmid P, Battegay M, Bernasconi E, Cavassini M, Calmy A, Keiser O, Schöni-Affolter F; the Swiss HIV Cohort Study.
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.
Br J Cancer. 2012 Jan 31;106(3):447-452. doi: 10.1038/bjc.2011.558. Epub 2012 Jan 12.
Butsch R, Lukas Waelti S, Schaerer S, Braun J, Korol D, Probst-Hensch N, Moch H, Kurrer M.
Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma.
Leuk Lymphoma. 2011 Jul;52(7):1230-8. Epub 2011 May 23.
Ess S, Joerger M, Frick H, Probst-Hensch N, Vlastos G, Rageth C, Lütolf U, Savidan A, Thürlimann B.
Predictors of state-of-the-art management of early breast cancer in Switzerland.
Ann Oncol. 2011 Mar;22(3):618-24. Epub 2010 Aug 12.
Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.
Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Hum Pathol. 2010 Nov;41(11):1558-65.
Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, Bouchardy C, Dehler S, Jundt G, Ess S, Bordoni A, Konzelmann I, Frick H, Dal Maso L, Elzi L, Furrer H, Calmy A, Cavassini M, Ledergerber B, Keiser O; Swiss HIV Cohort Study.
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
Br J Cancer. 2010 Jul 27;103(3):416-22. Epub 2010 Jun 29.
Albinger-Hegyi A, Stoeckli SJ, Schmid S, Storz M, Iotzova G, Probst-Hensch NM, Rehrauer H, Tinguely M, Moch H, Hegyi I.
Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC).
Int J Cancer. 2010 Jun 1;126(11):2653-62.
Riener MO, Fritzsche FR, Soll C, Pestalozzi BC, Probst-Hensch N, Clavien PA, Jochum W, Soltermann A, Moch H, Kristiansen G.
Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
Histopathology. 2010 Apr;56(5):600-6.
Leuenberger M, Frigerio S, Wild PJ, Noetzli F, Korol D, Zimmermann DR, Gengler C, Probst-Hensch NM, Moch H, Tinguely M.
AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations.
Mod Pathol. 2010 Feb;23(2):177-86. Epub 2009 Nov 6.
Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G, Chappuis PO, Ceschi M, Ess S, Castiglione M, Rapiti E, Verkooijen HM.
Impact of obesity on diagnosis and treatment of breast cancer.
Breast Cancer Res Treat. 2010 Feb;120(1):185-93. Epub 2009 Jul 14.
Probst-Hensch NM, Steiner JH, Schraml P, Varga Z, Zürrer-Härdi U, Storz M, Korol D, Fehr MK, Fink D, Pestalozzi BC, Lütolf UM, Theurillat JP, Moch H.
IGFBP2 and IGFBP3 Protein Expressions in Human Breast Cancer: Association with Hormonal Factors and Obesity.
Clin Cancer Res. 2010 Feb 1;16(3):1025-1032. Epub 2010 Jan 26.
Adam M, Weid NV, Michel G, Zwahlen M, Lutz JM, Probst-Hensch N, Niggli F, Kuehni C. for the Swiss Pediatric Oncology Group (SPOG)
Dr. med. R. Angst, Aarau; Prof. Dr. med. M. Paulussen, V. Stahel, Basel; Prof. Dr. med A. Hirt, K. Zimmermann, Bern; PD Dr. med A. H. Ozsahin, M. Berner, Geneva; PD Dr. med. N. von der Weid, PD Dr. med. M. Beck Popovic, Dr. med. E. Garcia, Lausanne; Dr. med. L. Nobile Buetti, Locarno; Dr. med. U. Caflisch, Y. Bonetti, Lucerne; Dr. med. J. Greiner, F. Hochreutener, St. Gallen; Prof. Dr. med. F. Niggli, H. Markiewicz, Zurich.
for the Swiss Association of Cancer Registries (ASRT)
Prof. Dr. G. Jundt, Basel City & Land; Dr. J.‐M. Lutz, Prof. Dr. C. Bouchardy, P. Pury, G. Fioretta, M. Usel, Geneva; Dr. H. Frick, A.‐M. Abutillo, Grisons & Glarus; Prof. Dr. F. Levi, Neuchatel; Dr. S. Ess, St. Gallen & Appenzell; Dr. A. Bordoni, A. Spitale, Ticino; Dr. D. De Weck, Dr. I. Konzelmann, Valais; Prof. Dr. F. Levi, Vaud; Prof. Dr. N. Probst, Dr. A. Kofler, Zurich.
Access to specialized pediatric cancer care in Switzerland.
Pediatr Blood Cancer. 2010 Jan 27.
Bordoni A, Probst-Hensch NM, Mazzucchelli L, Spitale A.
Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.
Br J Cancer. 2009 Dec 1;101(11):1925-31
Riener MO, Fritzsche FR, Clavien PA, Pestalozzi BC, Probst-Hensch N, Jochum W, Kristiansen G.
IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
Hum Pathol. 2009 Oct;40(10):1377-83
Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G.
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
Hepatology. 2009 May;49(5):1602-9
Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, Moch H, Kristiansen G.
Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
Clin Cancer Res. 2008 Nov 15;14(22):7430-7.
Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, Rauch A, Probst-Hensch NM, Bouchardy C, Levi F, Franceschi S; Swiss HIV Cohort.
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
AIDS. 2008 Oct 18;22(16):2135-41.
Umbehr M, Kessler TM, Sulser T, Kristiansen G, Probst N, Steurer J, Bachmann LM.
ProCOC: the prostate cancer outcomes cohort study.
BMC Urol. 2008 Jun 17;8:9.
Tinguely M, Jenni B, Knights A, Lopes B, Korol D, Rousson V, Curioni Fontecedro A, Cogliatti SB, Bittermann AG, Schmid U, Dommann-Scherrer C, Maurer R, Renner C, Probst-Hensch NM, Moch H, Knuth A, Zippelius A.
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Cancer Sci. 2008 Apr;99(4):720-5. Epub 2008 Feb 27
Opitz I, Soltermann A, Abaecherli M, Hinterberger M, Probst-Hensch N, Stahel R, Moch H, Weder W.
PTEN expression is a strong predictor of survival in mesothelioma patients.
Eur J Cardiothorac Surg. 2008 Mar;33(3):502-6. Epub 2008 Jan 8.
Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S; Swiss HIV Cohort Study.
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
AIDS. 2008 Jan 11;22(2):301-6.
Schmitt AM, Anlauf M, Rousson V, Schmid S, Kofler A, Riniker F, Bauersfeld J, Barghorn A, Probst-Hensch NM, Moch H, Heitz PU, Kloeppel G, Komminoth P, Perren A.
WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Am J Surg Pathol. 2007 Nov;31(11):1677-82.
Tinguely M, Jenni B, Reineke T, Korol D, Kofler A, Rousson V, Dommann-Scherrer C, Maurer R, Moch H, Probst-Hensch NM.
Chromosomal Translocations t(4;14), t(11;14) and Proliferation Rate Stratify Patients With Mature Plasma Cell Myelomas Into Groups With Different Survival Probabilities-A Molecular Epidemiologic Study on Tissue Microarrays.
Am J Surg Pathol. 2007 May;31(5):690-696.
Theurillat JP, Zurrer-Hardi U, Varga Z, Storz M, Probst-Hensch NM, Seifert B, Fehr MK, Fink D, Ferrone S, Pestalozzi B, Jungbluth AA, Chen YT, Jager D, Knuth A, Moch H.
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Cancer Immunol Immunother. 2007 Apr 5
Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch N.
Epidemiology and pathophysiology of obesity as cause of cancer.
Swiss Med Wkly. 2007 Jan 27;137(3-4):50-6.
Franceschi S, Polesel J, Rickenbach M, Dal Maso L, Probst-Hensch NM, Fux C, Cavassini M, Hasse B, Kofler A, Ledergerber B, Erb P, Clifford GM.
Hepatitis C virus and non-Hodgkin’s lymphoma: findings from the Swiss HIV Cohort Study.
Br J Cancer. 2006 Nov 14
Fisch T, Pury P, Probst N, Bordoni A, Bouchardy C, Frick H, Jundt G, De Weck D, Perret E, Lutz JM.
Variation in survival after diagnosis of breast cancer in Switzerland.
Ann Oncol. 2005 Dec;16(12):1882-8. Epub 2005 Oct 10.
Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.
Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P.
Genetic pathways to glioblastoma: a population-based study.
Cancer Res. 2004 Oct 1;64(19):6892-9.
Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Acta Neuropathol. 2004 Jul;108(1):49-56. Epub 2004 Apr 28.
Zwahlen M, Bopp M, Probst-Hensch NM.
Mammography screening in Switzerland: limited evidence from limited data.
Swiss Med Wkly. 2004 May 29;134(21-22):295-306
Burkhard C, Di Patre PL, Schüler D, Schüler G, Yaşargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.
J Neurosurg. 2003 Jun;98(6):1170-4.
Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, Strnad M, Jechov’a M, Storm HH, Aareleid T, Hakulinen T, Velten M, Lef’evre H, Danzon A, Buemi A, Daur’es JP, Ménégoz F, Raverdy N, Sauvage M, Ziegler H, Comber H, Paci E, Vercelli M, De Lisi V, Tumino R, Zanetti R, Berrino F, Stanta G, Langmark F, Rachtan J, Mezyk R, Blaszczyk J, Ivan P, Primic-Zakelj M, Martínez AC, Izarzugaza I, Borràs J, Garcia CM, Garau I, Sánchez NC, Aicua A, Barlow L, Torhorst J, Bouchardy C, Levi F, Fisch T, Probst N, Visser O, Quinn M, Gavin A, Brewster D, Mikov M; ENCR Working Group.
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends.
Cancer Causes Control. 2003 Oct;14(8):791-803. Erratum in: Cancer Causes Control. 2004 Feb;15(1):103.
Semen quality of young men in Switzerland: a nationwide cross-sectional population-based study.
Rahban R, Priskorn L, Senn A, Stettler E, Galli F, Vargas J, Van den Bergh M, Fusconi A, Garlantezec R, Jensen TK, Multigner L, Skakkebaek NE, Germond M, Jørgensen N, Nef S; NICER Working Group. Andrology. 2019 Nov;7(6):818-826. doi: 10.1111/andr.12645. Epub 2019 May 21. PMID: 31115178
Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.
Kollár A, Rothermundt C, Klenke F, Bode B, Baumhoer D, Arndt V, Feller A; NICER Working Group.Cancer Epidemiol. 2019 Dec;63:101596. doi: 10.1016/j.canep.2019.101596. Epub 2019 Sep 11.PMID: 31520938
Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment?
Jegerlehner S, Chiolero A, Aujesky D, Rodondi N, Germann S, Konzelmann I, Bulliard JL; NICER Working Group. PLoS One. 2019 Feb 4;14(2):e0210434. doi: 10.1371/journal.pone.0210434. eCollection 2019. PMID: 30716740
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries.
Benzarti S, Daskalakis M, Feller A, Bacher VU, Schnegg-Kaufmann A, Rüfer A, Holbro A, Schmidt A, Benz R, Solenthaler M, Stussi G, Arndt V, Bonadies N; NICER Working Group. Cancer Epidemiol. 2019 Apr;59:51-57. doi: 10.1016/j.canep.2019.01.003. Epub 2019 Jan 25. PMID: 30690330
Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population-based study.
Feller A, Schmidlin K, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Konzelmann I, Maspoli M, Wanner M, Zwahlen M, Clough-Gorr KM; SNC and the NICER Working Group. Cancer Med. 2018 Apr;7(4):1498-1510. doi: 10.1002/cam4.1385. Epub 2018 Feb 26. PMID: 29479854
Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013.
Andres M, Feller A, Arndt V; NICER Working Group.Cancer Epidemiol. 2018 Apr;53:105-110. doi: 10.1016/j.canep.2018.01.015. Epub 2018 Feb 6.PMID: 29414629
Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013. Schnegg-Kaufmann A, Feller A, Baldomero H, Rovo A, Manz MG, Gregor M, Efthymiou A, Bargetzi M, Hess U, Spertini O, Chalandon Y, Passweg JR, Stussi G, Arndt V, Bonadies N; NICER Working Group.Cancer Epidemiol. 2018 Feb;52:55-62. doi: 10.1016/j.canep.2017.11.008. Epub 2017 Dec 7.PMID: 29223104
Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study.
Jegerlehner S, Bulliard JL, Aujesky D, Rodondi N, Germann S, Konzelmann I, Chiolero A; NICER Working Group. PLoS One. 2017 Jun 14;12(6):e0179387. doi: 10.1371/journal.pone.0179387. eCollection 2017. PMID: 28614405
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012.
Bonadies N, Feller A, Rovo A, Ruefer A, Blum S, Gerber B, Stuessi G, Benz R, Cantoni N, Holbro A, Schmidt A, Lehmann T, Wilk CM, Arndt V; NICER Working Group. Cancer Epidemiol. 2017 Feb;46:85-92. doi: 10.1016/j.canep.2016.12.005. Epub 2017 Jan 2. PMID: 28056392
Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.
Feller A, Fehr M, Bordoni A, Bouchardy C, Frick H, Mousavi M, Steiner A, Arndt V, Clough-Gorr KM; Nicer Working Group. Swiss Med Wkly. 2015 Dec 10;145:w14245. doi: 10.4414/smw.2015.14245. eCollection 2015. PMID: 26661828
Breast cancer in younger women in Switzerland 1996-2009: a longitudinal population-based study.
Bodmer A, Feller A, Bordoni A, Bouchardy C, Dehler S, Ess S, Levi F, Konzelmann I, Rapiti E, Steiner A, Clough-Gorr KM; NICER Working Group. Breast. 2015 Apr;24(2):112-7. doi: 10.1016/j.breast.2014.11.004. Epub 2014 Dec 15. PMID: 25522906